Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

ASH 2010

4 - 7 Dec 2010
Cairo, Egypt
The use of maintenance treatments in myeloma patients
Prof Antonio Palumbo - Molinette Hospital, Turin, Italy and Prof Vincent Rajkuma...
The use of maintenance treatments in myeloma patients ( Prof Antonio Palumbo - Molinette Hospital, Turin, Italy and Prof Vincent Rajkumar - Mayo Clinic, Arizona, USA )
1 Mar 2011
Key advances in the treatment of lymphoma from ASH 2010
Prof Mathias Rummel, Dr Umberto Vitolo, Prof Johannes Drach, Prof Christian Busk...
Key advances in the treatment of lymphoma from ASH 2010 ( Prof Mathias Rummel, Dr Umberto Vitolo, Prof Johannes Drach, Prof Christian Buske, Prof Owen O'Connor )
28 Feb 2011
Optimal treatment of multiple myeloma
Prof Meletios Dimopoulos, Prof Hermann Einsele, Prof Mario Boccadoro, Dr Maria-V...
Optimal treatment of multiple myeloma ( Prof Meletios Dimopoulos, Prof Hermann Einsele, Prof Mario Boccadoro, Dr Maria-Victoria Mateos )
28 Feb 2011
The history of bendamustine
Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany
The history of bendamustine ( Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany )
28 Feb 2011
The role of bendamustine in the treatment of mantle cell lymphomas
Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany
The role of bendamustine in the treatment of mantle cell lymphomas ( Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany )
28 Feb 2011
First-line Indolent Trial (FIT) study
Prof Anton Hagenbeek - Academic Medical Center, Amsterdam, Netherlands
First-line Indolent Trial (FIT) study ( Prof Anton Hagenbeek - Academic Medical Center, Amsterdam, Netherlands )
23 Feb 2011
Changing the paradigm in frontline CML therapy
Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis...
Changing the paradigm in frontline CML therapy ( Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network )
21 Feb 2011
Burkitt’s lymphoma in the elderly
Dr Antonio Pinto - Fondazione ‘G. Pascale’, Naples, Italy
Burkitt’s lymphoma in the elderly ( Dr Antonio Pinto - Fondazione ‘G. Pascale’, Naples, Italy )
21 Feb 2011
The role of comorbidity indices in the prognosis of elderly MDS patients
Prof Valeria Santini - University of Florence, Italy
The role of comorbidity indices in the prognosis of elderly MDS patients ( Prof Valeria Santini - University of Florence, Italy )
21 Feb 2011
Key research presented at ASH 2010
Prof George Canellos - Harvard Medical School, Boston, USA
Key research presented at ASH 2010 ( Prof George Canellos - Harvard Medical School, Boston, USA )
21 Feb 2011
Administration of bortezomib in multiple myeloma patients
Prof Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France
Administration of bortezomib in multiple myeloma patients ( Prof Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France )
18 Feb 2011
Bosutinib as a treatment for newly diagnosed chronic myeloid leukaemia
Prof Carlo Gambacorti-Passerini - University of Milan Bicocca, Italy
Bosutinib as a treatment for newly diagnosed chronic myeloid leukaemia ( Prof Carlo Gambacorti-Passerini - University of Milan Bicocca, Italy )
18 Feb 2011
DASISION study on cardiovascular safety in patients with CML-CP
Prof Giuseppe Saglio - University of Turin, Italy
DASISION study on cardiovascular safety in patients with CML-CP ( Prof Giuseppe Saglio - University of Turin, Italy )
18 Feb 2011
The role of epigenetics in cancer treatment
Prof Stephen Baylin - Johns Hopkins University, Maryland, USA
The role of epigenetics in cancer treatment ( Prof Stephen Baylin - Johns Hopkins University, Maryland, USA )
18 Feb 2011
Progress in the treatment of CML
Dr Jerald Radich - Fred Hutchinson Cancer Research Center, Seattle, USA
Progress in the treatment of CML ( Dr Jerald Radich - Fred Hutchinson Cancer Research Center, Seattle, USA )
18 Feb 2011
Blood cancers in the elderly
Jan Geissler - Co-Founder, CML Advocates Network
Blood cancers in the elderly ( Jan Geissler - Co-Founder, CML Advocates Network )
18 Feb 2011
Key CML research from ASH 2010
Jan Geissler - Co-Founder, CML Advocates Network
Key CML research from ASH 2010 ( Jan Geissler - Co-Founder, CML Advocates Network )
18 Feb 2011
Advances in the treatment of CLL
Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA
Advances in the treatment of CLL ( Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA )
18 Feb 2011
The role of plasma cell biology in multiple myeloma
Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
The role of plasma cell biology in multiple myeloma ( Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
18 Feb 2011
Key multiple myeloma research from ASH 2010
Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands
Key multiple myeloma research from ASH 2010 ( Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands )
18 Feb 2011
CLL related research from ASH 2010
Dr Michael Keating- MD Anderson Cancer Center, Texas, USA
CLL related research from ASH 2010 ( Dr Michael Keating- MD Anderson Cancer Center, Texas, USA )
18 Feb 2011
The DASISION chronic myeloid leukaemia trial
Dr Neil Shah - University of California, San Francisco, USA
The DASISION chronic myeloid leukaemia trial ( Dr Neil Shah - University of California, San Francisco, USA )
18 Feb 2011
Key lymphoma research from ASH 2010
Prof Wyndham Wilson - National Cancer Institute, Maryland, USA
Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )
18 Feb 2011
The importance of myelodysplastic syndrome diagnosis
Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria
The importance of myelodysplastic syndrome diagnosis ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )
18 Feb 2011
Haematological cancers in the elderly
Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria
Haematological cancers in the elderly ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )
18 Feb 2011
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy
Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Aus...
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy ( Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia )
18 Feb 2011
Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma
Prof Andre Goy - Hackensack University Medical Center, New Jersey, USA
Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma ( Prof Andre Goy - Hackensack University Medical Center, New Jersey, USA )
13 Feb 2011
Temsirolimus and clofarabine for the treatment of elderly AML patients
Prof Sergio Amadori - Tor Vergata University Hospital, Rome, Italy
Temsirolimus and clofarabine for the treatment of elderly AML patients ( Prof Sergio Amadori - Tor Vergata University Hospital, Rome, Italy )
13 Feb 2011
The treatment of haematological cancer in older patients
Prof Sergio Amadori - Tor Vergata University Hospital, Rome, Italy
The treatment of haematological cancer in older patients ( Prof Sergio Amadori - Tor Vergata University Hospital, Rome, Italy )
13 Feb 2011
ecancer symposium on the treatment of elderly patients with haematological cance...
Prof Lodovico Balducci - Moffitt Cancer Center, Florida, USA
ecancer symposium on the treatment of elderly patients with haematological cancer ( Prof Lodovico Balducci - Moffitt Cancer Center, Florida, USA )
13 Feb 2011
Senior Adult Oncology Program at Moffitt Cancer Center
Prof Lodovico Balducci - Moffitt Cancer Center, Florida, USA
Senior Adult Oncology Program at Moffitt Cancer Center ( Prof Lodovico Balducci - Moffitt Cancer Center, Florida, USA )
13 Feb 2011
Factors influencing treatment of elderly cancer patients
Prof Antonio Palumbo - University of Turin, Italy
Factors influencing treatment of elderly cancer patients ( Prof Antonio Palumbo - University of Turin, Italy )
13 Feb 2011
Ofatumumab treatment for chronic lymphocytic leukaemia
Dr William Wierda - University of Texas, USA
Ofatumumab treatment for chronic lymphocytic leukaemia ( Dr William Wierda - University of Texas, USA )
13 Feb 2011
Role of bortezomib in the treatment of follicular lymphoma
Prof Bertrand Coiffier - Hospices Civils de Lyon, France
Role of bortezomib in the treatment of follicular lymphoma ( Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
13 Feb 2011
Haematological cancers in the elderly
Prof Bertrand Coiffier - Hospices Civils de Lyon, France
Haematological cancers in the elderly ( Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
13 Feb 2011
The role of the European Hematology Association
Prof Robin Foà - Sapienza University of Rome, Italy
The role of the European Hematology Association ( Prof Robin Foà - Sapienza University of Rome, Italy )
13 Feb 2011
Haematological cancer in the elderly
Prof Robin Foà - Sapienza University of Rome, Italy
Haematological cancer in the elderly ( Prof Robin Foà - Sapienza University of Rome, Italy )
13 Feb 2011